This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Phadia Ab, Kimberly-Clark Worldwide, Inc.. Active years: 2008-2015.
Location History:
- Rhondda Cynon Taf, GB (2008 - 2011)
- Pontypridd, GB (2015)
Company Filing History:
Years Active: 2008-2015
Title: Innovations by Paul Christopher in Lateral Flow Assay Technology
Introduction
Paul Christopher is an accomplished inventor based in Rhondda Cynon Taf, GB. He has made significant contributions to the field of lateral flow assay technology, holding a total of 3 patents. His work focuses on methods and devices that enhance the detection of IgE antibodies in various samples.
Latest Patents
Among his latest patents, Paul Christopher has developed two notable innovations. The first patent describes a two-step lateral flow assay method for identifying IgE antibodies in a sample. This method involves applying a sample to a device that delivers it to a lateral flow matrix containing multiple IgE antigen species. The sample travels along the matrix, allowing for the detection of IgE antibodies through a visible change at a downstream location. The second patent also pertains to lateral flow assay devices and methods for detecting analytes in samples. This method similarly involves applying a sample to a device and utilizing a water-soluble mark to enhance detection accuracy.
Career Highlights
Throughout his career, Paul Christopher has worked with notable companies such as Phadia AB and Kimberly-Clark Worldwide, Inc. His experience in these organizations has contributed to his expertise in developing innovative assay technologies.
Collaborations
Paul has collaborated with esteemed colleagues, including Gerd Rundström and Per Matsson. These partnerships have further enriched his work and led to advancements in the field.
Conclusion
Paul Christopher's contributions to lateral flow assay technology demonstrate his commitment to innovation and excellence. His patents reflect a deep understanding of the complexities involved in detecting IgE antibodies, paving the way for advancements in diagnostic methods.